Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Ototoxicity, Deafness, Dizziness, Head and Neck Neoplasms, Hearing Loss, Sensorineural, Vestibular Diseases, Hearing Loss

NCT05641441 2025-01-13

Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma

Recruiting

258 enrolled

CNS

Ototoxicity, Neuroma, Acoustic, Hearing Loss

NCT03745560 2024-11-25

Intraoperative EABR for Decision Making

Recruiting

15 enrolled

CNS

Neuroma, Acoustic, Hearing Loss

NCT04609982 2024-08-21

SSNHL in Head & Neck Cancer Patients

Phase NA Withdrawn

Hearing Loss

NCT03914378 2024-05-08

EARAD

Recruiting

100 enrolled

Head & Neck

Head and Neck Neoplasms, Hearing Loss

NCT06016335 2023-12-19

MRI-based Synthetic CT Images of the Head and Neck

Phase NA Completed

80 enrolled

Head & Neck

Cholesteatoma, Head and Neck Neoplasms, Sinusitis, Hearing Loss

NCT04291209 2023-09-06

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

Phase 1/2 Unknown

80 enrolled

Deafness, Ear Diseases, Hearing Loss, Sensorineural, Hearing Loss

NCT05946577 2023-07-14

AURACCO

Not yet recruiting

140 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Ototoxicity, Head and Neck Neoplasms, Salivary Gland Neoplasms, Tinnitus, Hearing Loss

NCT04262336 2023-07-06

Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment

Phase 1 Completed

22 enrolled

Ototoxicity, Hearing Loss

NCT02094625 2023-04-18

NAC to Prevent Cisplatin-induced Hearing Loss

Phase 1 Completed

52 enrolled

GastrointestinalSarcoma

Liver Neoplasms, Osteosarcoma, Neuroectodermal Tumors, Primitive, Hearing Loss

NCT02778295 2023-02-13

BioFabry

Withdrawn

Angiokeratoma, Fabry Disease, Hearing Loss, Renal Insufficiency, Chronic

NCT05633719 2022-12-01

Multicenter, Prospective Observational Study for Early Diagnosis, and Development of Follow-up Protocol and Hearing Rehabilitation Program for Ototoxic Hearing Loss After Chemotherapy for Pediatric Solid Cancer

Not yet recruiting

300 enrolled

Hearing Loss

NCT04132882 2021-09-16

A Compassionate Use Program to Provide Access to Sodium Thiosulfate

Available

Gastrointestinal

Hepatoblastoma, Hearing Loss

NCT04505696 2020-10-08

Providing Speech Therapy Awareness in Private Schools

Phase NA Completed

138 enrolled

Head & Neck

Developmental Disabilities, Communication Disorders, Deglutition Disorders, Head and Neck Neoplasms, Language Development Disorders, Language Disorders, Speech, Stuttering, Hearing Loss

NCT01864291 2020-06-02

ABI

Phase NA Terminated

9 enrolled 10 charts

Deafness, Hearing Loss

NCT01736267 2020-05-06

Auditory Brainstem Implant (ABI) in Adult Non-Neurofibromatosis Type 2 Subjects

Phase NA Terminated

3 enrolled 8 charts

Deafness, Hearing Loss

NCT02381782 2018-02-15

UHEAR

Completed

33 enrolled

Neoplasms, Hearing Loss

NCT01451853 2017-09-25

SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss

Phase 2 Unknown

80 enrolled

Head & NeckThoracic

Ototoxicity, Deafness, Head and Neck Neoplasms, Lung Neoplasms, Tinnitus, Hearing Loss

NCT01969370 2017-05-03

NCGENES

Phase NA Completed

645 enrolled

Congenital Abnormalities, Cardiovascular Diseases, Neoplasms, Neurologic Manifestations, Neurodegenerative Diseases, Hearing Loss

NCT01452607 2016-06-29

Study to Evaluate the Safety and Pharmacokinetics of SPI-1005

Phase 1 Completed

32 enrolled

Neoplasms, Hearing Loss

NCT00584155 2015-05-27

Protection From Cisplatin Ototoxicity by Lactated Ringers

Phase 1 Withdrawn

Ear Neoplasms, Hearing Loss

NCT00004437 2015-03-25

Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2

Phase 2 Completed

CNS

Mental Disorders, Neurologic Manifestations, Neuroma, Acoustic, Neurofibromatosis 2, Neurofibromatoses, Genetic Diseases, Inborn, Hearing Loss, Rare Diseases

NCT01225978 2014-01-24

RISGIM

Unknown

40 enrolled

Cardiomyopathy, Hypertrophic, Neoplasms, Hearing Loss

NCT01102621 2010-04-13

Hearing Loss and Complaint in Patients With Head and Neck Cancer Treated With Radiotherapy

Completed

282 enrolled

Head & Neck

Head and Neck Neoplasms, Hearing Loss

Clinical Trials

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma

Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis

Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)

New Approach to Objectively Measure Social Engagement in Older Adults With Hearing Loss

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

NIDCD Otolaryngology Clinical Protocol Biospecimen Bank

Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory Nerves

HEAR

HSA50+

CaSPiN

Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer

Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma

Intraoperative EABR for Decision Making

SSNHL in Head & Neck Cancer Patients

EARAD

MRI-based Synthetic CT Images of the Head and Neck

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

AURACCO

Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment

NAC to Prevent Cisplatin-induced Hearing Loss

BioFabry

Multicenter, Prospective Observational Study for Early Diagnosis, and Development of Follow-up Protocol and Hearing Rehabilitation Program for Ototoxic Hearing Loss After Chemotherapy for Pediatric Solid Cancer

A Compassionate Use Program to Provide Access to Sodium Thiosulfate

Providing Speech Therapy Awareness in Private Schools

ABI

Auditory Brainstem Implant (ABI) in Adult Non-Neurofibromatosis Type 2 Subjects

UHEAR

SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss

NCGENES

Study to Evaluate the Safety and Pharmacokinetics of SPI-1005

Protection From Cisplatin Ototoxicity by Lactated Ringers

Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2

RISGIM

Hearing Loss and Complaint in Patients With Head and Neck Cancer Treated With Radiotherapy